Anti-fungal Therapeutics Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Anti-fungal Therapeutics Market – Report Overview

Pacific Business Consulting’s “Anti-fungal Therapeutics Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Anti-fungal Therapeutics market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

The global Anti-fungal Therapeutics market, valued at US$ 11.2 Billion in 2022, is projected to expand at a CAGR of more than 4% from 2023 to 2030, reaching an estimated valuation of US$ 19.6 Billion by 2030. The demand for anti-fungal therapies is expected to grow during this period due to the increasing cases of fungal diseases such as candidiasis, aspergillosis, and onychomycosis.

Key Factors Driving the Anti-fungal Therapeutics Market Growth:

Rising Incidence of Fungal Diseases: The market is driven by the increasing prevalence of fungal infections like candidiasis, aspergillosis, and onychomycosis, leading to a higher demand for anti-fungal therapies.

Mycosis Control and Treatment: Anti-fungal therapies play a crucial role in mycosis control and treatment, contributing to market growth.

Ongoing Developments in Novel Treatments: Ongoing developments in the discovery of novel treatments for fungal diseases by the pharmaceutical industry contribute to the expansion of the market.

Fungal Infections of Eyes, Mouth, and Skin: Fungal infections affecting various body parts, including the eyes, mouth, and skin, are expected to drive market expansion.

Availability and Adoption of Generic Antifungal Drugs: The availability and effective adoption of generic antifungal drugs like miconazole, clotrimazole, and econazole create significant opportunities in the market.

Challenges and Limitations:

Side Effects of Antifungal Therapy: Some antifungal therapies may cause harmful side effects, including heart arrhythmia, oliguria, promethazine, and muscle spasms or pain, posing challenges to patient treatment.

Strict Government Regulations: Strict government regulations, patent expirations, and increasing fungal resistance to drugs are expected to hamper market growth.

Drug Recall Rates: Rising drug recall rates may negatively impact the expansion of the anti-fungal therapy market.

Despite the challenges, the market is expected to grow, with key players such as Johnson & Johnson, MerzPharma, Enzon Pharmaceuticals Inc., Glenmark, Dr. Reddy’s Laboratories, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Sanofi S.A, Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc, GlaxoSmithKline Plc, Merck & Co. Inc., and Novartis A.G. playing pivotal roles in shaping the industry landscape.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Anti-fungal Therapeutics market. It also delves into the analysis of present and prospective market competition within the global Anti-fungal Therapeutics market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Anti-fungal Therapeutics market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Anti-fungal Therapeutics market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Anti-fungal Therapeutics
   • Global Market Outlook: Anti-fungal Therapeutics
2. Competitive Intelligence Analysis: Anti-fungal Therapeutics
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Anti-fungal Therapeutics
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Anti-fungal Therapeutics
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Anti-fungal Therapeutics: Ten Major Market (10MM) – Market Analysis, By Drug Class
   • Polyene Macrolides
   • Azoles
   • Allylamines
   • Echinocandins
   • Others
9. Anti-fungal Therapeutics: Ten Major Market (10MM) – Market Analysis, By Route of Administration
   • Oral
   • Parenteral
   • Topical
10. Anti-fungal Therapeutics: Ten Major Market (10MM) – Market Analysis, By Distribution Channel
    • Online Channels
    • Hospitals Pharmacies
    • Pharmacies & Drug Stores
11. Anti-fungal Therapeutics: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

12. S. Anti-fungal Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

13. K. Anti-fungal Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

14. Germany Anti-fungal Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

15. France Anti-fungal Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

16. Italy Anti-fungal Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

17. Spain Anti-fungal Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

18. Japan Anti-fungal Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

19. China Anti-fungal Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

20. Australia Anti-fungal Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

21. India Anti-fungal Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Drug Class
      • By Route of Administration
      • By Distribution Channel

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer